0001209191-21-070094.txt : 20211216
0001209191-21-070094.hdr.sgml : 20211216
20211216204742
ACCESSION NUMBER: 0001209191-21-070094
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211215
FILED AS OF DATE: 20211216
DATE AS OF CHANGE: 20211216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Randolph Sophia
CENTRAL INDEX KEY: 0001817127
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 211499314
MAIL ADDRESS:
STREET 1: C/O ALX ONCOLOGY HOLDINGS INC.
STREET 2: 866 MALCOLM ROAD, SUITE 100
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-15
0
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001817127
Randolph Sophia
C/O ALX ONCOLOGY HOLDINGS INC.
866 MALCOLM ROAD, SUITE 100
BURLINGAME
CA
94010
1
1
0
0
Chief Medical Officer
Common Stock
2021-12-15
4
M
0
12793
0.99
A
177337
D
Common Stock
2021-12-15
4
M
0
11059
1.91
A
188396
D
Stock Option (right to buy)
0.99
2021-12-15
4
M
0
12793
0.00
D
2027-03-30
Common Stock
12793
0
D
Stock Option (right to buy)
1.91
2021-12-15
4
M
0
11059
0.00
D
2029-09-12
Common Stock
11059
12431
D
Shares subject to the option are fully vested and immediately exercisable.
The option is subject to an early exercise provision and is immediately exercisable. Shares subject to the option vest in 48 equal monthly installments beginning on April 9, 2020.
/s/ Peter Garcia, by power of attorney
2021-12-16